InvestorsHub Logo
Followers 59
Posts 2025
Boards Moderated 1
Alias Born 05/07/2003

Re: None

Friday, 10/23/2009 11:58:38 AM

Friday, October 23, 2009 11:58:38 AM

Post# of 64411
Whether or not Cobroxin works isn't the issue.

The issue is that NPHC has no rights to sell the product as they granted that right to XCHO. We don't know the terms of that deal.

There are other issues. For example, what proprietary rights does NPHC have to this product? If anyone can make it, or something similar, then how can you believe earnings would be enough to justify a $125 market cap.

Without that basic information it is impossible to value NPHC. That's why the whole stock is just a silly exercise in trying to fool the public. A real company serious about its product would not be public at this stage to begin with. If it was public it would certainly provide its investors with the basic fundamental information necessary to determine a reasonable range of value.

That NPHC does not take its investors seriously means that NPHC is not serious about being in business for the long term. They are simply pushing out stock at this inflated valuation.

But.... they don't have to fool everyone. Just enough people to buy a few million dollars of useless stock.